Mey V[au] - Search Results

Year	Number of Results
2004	2
2005	3
2006	5
2007	2
2008	2
2009	3
2010	3
2011	1
2013	2
2015	1
2020	1
2022	0

1

Mobile Robotic Telepresence Between Hospital and School: Lessons Learned.

Schmucker M, Reiswich A, Pfeifer C, De Mey V, Haag M. Schmucker M, et al. Among authors: de mey v. Stud Health Technol Inform. 2020 Jun 23;271:256-262. doi: 10.3233/SHTI200104. Stud Health Technol Inform. 2020. PMID: 32578571

2

In vitro studies on gemcitabine combinations with other antiblastics.

Giovannetti E, Danesi R, Mey V, Nannizzi S, Pasqualetti G, Del Tacca M. Giovannetti E, et al. Among authors: mey v. Ann Oncol. 2006 May;17 Suppl 5:v17-19. doi: 10.1093/annonc/mdj943. Ann Oncol. 2006. PMID: 16807450 Free article. Review.

3

Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer.

Giovannetti E, Mey V, Nannizzi S, Pasqualetti G, Del Tacca M, Danesi R. Giovannetti E, et al. Among authors: mey v. Mol Cancer Ther. 2006 Jun;5(6):1387-95. doi: 10.1158/1535-7163.MCT-06-0004. Mol Cancer Ther. 2006. PMID: 16818496 Review.

4

Synthesis of Novel 3,5-Disubstituted-2-oxindole Derivatives As Antitumor Agents against Human Nonsmall Cell Lung Cancer.

Nesi G, Sestito S, Mey V, Ricciardi S, Falasca M, Danesi R, Lapucci A, Breschi MC, Fogli S, Rapposelli S. Nesi G, et al. Among authors: mey v. ACS Med Chem Lett. 2013 Oct 18;4(12):1137-41. doi: 10.1021/ml400162g. eCollection 2013 Dec 12. ACS Med Chem Lett. 2013. PMID: 24900620 Free PMC article.

5

Akt1 rs2498801 is related to survival in head and neck squamous cell cancer treated with radiotherapy.

Pasqualetti F, Bocci G, Mey V, Menghini V, Montrone S, Cocuzza P, Ferrazza P, Seccia V, Delishaj D, Orlandini C, Fabrini MG, Danesi R. Pasqualetti F, et al. Among authors: mey v. Anticancer Res. 2015 Jan;35(1):269-71. Anticancer Res. 2015. PMID: 25550560

6

Synergistic interaction between PPAR ligands and salbutamol on human bronchial smooth muscle cell proliferation.

Fogli S, Stefanelli F, Picchianti L, Del Re M, Mey V, Bardelli C, Danesi R, Breschi MC. Fogli S, et al. Among authors: mey v. Br J Pharmacol. 2013 Jan;168(1):266-75. doi: 10.1111/j.1476-5381.2012.02180.x. Br J Pharmacol. 2013. PMID: 22924744 Free PMC article.

7

Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines.

Crea F, Giovannetti E, Cortesi F, Mey V, Nannizzi S, Gallegos Ruiz MI, Ricciardi S, Del Tacca M, Peters GJ, Danesi R. Crea F, et al. Among authors: mey v. Mol Cancer Ther. 2009 Jul;8(7):1964-73. doi: 10.1158/1535-7163.MCT-09-0027. Epub 2009 Jun 16. Mol Cancer Ther. 2009. PMID: 19531575

8

Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma.

Funel N, Giovannetti E, Del Chiaro M, Mey V, Pollina LE, Nannizzi S, Boggi U, Ricciardi S, Del Tacca M, Bevilacqua G, Mosca F, Danesi R, Campani D. Funel N, et al. Among authors: mey v. Lab Invest. 2008 Jul;88(7):773-84. doi: 10.1038/labinvest.2008.40. Epub 2008 May 19. Lab Invest. 2008. PMID: 18490900

9

Synergistic cytotoxicity and molecular interaction on drug targets of sorafenib and gemcitabine in human pancreas cancer cells.

Ricciardi S, Mey V, Nannizzi S, Pasqualetti G, Crea F, Del Tacca M, Danesi R. Ricciardi S, et al. Among authors: mey v. Chemotherapy. 2010;56(4):303-12. doi: 10.1159/000320031. Epub 2010 Aug 13. Chemotherapy. 2010. PMID: 20714148

10

Synergistic cytotoxicity, inhibition of signal transduction pathways and pharmacogenetics of sorafenib and gemcitabine in human NSCLC cell lines.

Pasqualetti G, Ricciardi S, Mey V, Del Tacca M, Danesi R. Pasqualetti G, et al. Among authors: mey v. Lung Cancer. 2011 Nov;74(2):197-205. doi: 10.1016/j.lungcan.2011.03.003. Epub 2011 May 6. Lung Cancer. 2011. PMID: 21529991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results